Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder

Status:
Completed

Trial end date:
2004-05-01

Target enrollment:

Participant gender:

The study is to assess the performance characteristics of a new measure to assess onset of efficacy in a GAD patient population.

N/A

Pfizer

Lorazepam
Paroxetine